19 results
Causes of Peripheral Weakness without Sensory Changes - Differential Diagnosis Algorithm
No Objective Weakness
 • Cardio-pulmonary disease
Weakness • Cardio-pulmonary ... muscular atrophy • Hodgkin's ... Lambert-Eaton Myasthenic Syndrome ... Dystrophy • Statin ... Peripheral #Weakness #Neurology
COVID-19 - A Seattle Intensivist's One-Page Cheat-Sheet on COVID-19 v2.7 Updated March 26 2020

(v2.7) incorporating newer
as data on new treatment ... US and updated treatment ... 10% GI symptoms Imaging ... unilateral* • POCUS ... Cheatsheet #Diagnosis #Management
Myasthenia Gravis Overview

Myasthenia Gravis is an autoimmune disorder of the postsynaptic neuromuscular junction.  Ab to
effects of SCC or Hodgkin ... thyroid, Sjogren syndrome ... Imaging - CT Chest ... Gravis #diagnosis #management ... #neurology
CNS Manifestations of Systemic Lupus Erythematosus (SLE)

Clinical Manifestations: Demyelinating Syndrome, Headache, Movement disorders, Seizure disorders, Aseptic
Demyelinating Syndrome ... Puncture, EEG Treatment ... Secondary prevention (statin ... cerebritis #diagnosis #management ... #treatment
Shock - Differential Diagnosis Framework
 - MAP <65. SBP <90, drop in SBP > 40
 -
• Obstructive: Pulmonary ... Abdominal compartment syndrome ... Losses, Third Spacing ... Dehydration Shock Treatment ... #management
Pulmonary Renal Syndromes - OnePager Summary
Autoimmune ANCA vasculitis (AAV): GPA (granulomatous with polyangiitis), EGPA (eosinophilic granulomatosis
Syndromes - OnePager ... Renal Syndromes ... crescents) • IF staining ... differential #diagnosis #management ... #treatment
An Algorithm for the Management of Seizures

The management of active seizures is algorithmic, starting with a
Algorithm for the Management ... is algorithmic, starting ... Pharmacologic treatment ... The focus is on ... #Emergency #Neurology
Diuretics and Agents Regulating Renal Excretion

Carbonic Anhydrase Inhibitors (Acetazolamide, Dichlorphenamide)
 • Glaucoma
 • Epilepsy
 • Altitude
irrigation • Management ... Torsemide) • Acute pulmonary ... Antagonists, K+ Sparing ... Tolvaptan) • Treatment ... Excretion #Diuresis #Nephrology
Guillain-Barre Syndrome - Summary

Acute AIDP that presents with rapidly progressive flaccid weakness

Epidemiology:
 • 1-2 cases/100,000 per
Guillain-Barre Syndrome ... like illnesses, COVID ... Treatment: • Plasmapheresis ... #diagnosis #management ... #treatment #neurology
Differentiation Syndrome in APML
Epidemiology:
 • Incidence: common in APL (2-48% depending on the study)
 • Triggers:
Differentiation Syndrome ... Triggers: ATRA treatment ... : CXR- pulmonary ... Renal Failure Treatment ... APML #diagnosis #management